The identification of human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin (HA) stem revitalized hopes of developing a universal influenza vaccine. Using a rational design and library approach, we engineered stable HA stem antigens ("mini-HAs") based on an H1 subtype sequence. Our most advanced candidate exhibits structural and bnAb binding properties comparable to those of full-length HA, completely protects mice in lethal heterologous and heterosubtypic challenge models, and reduces fever after sublethal challenge in cynomolgus monkeys. Antibodies elicited by this mini-HA in mice and nonhuman primates bound a wide range of HAs, competed with human bnAbs for HA stem binding, neutralized H5N1 viruses, and mediated antibody-dependent effector activity. These results represent a proof of concept for the design of HA stem mimics that elicit bnAbs against influenza A group 1 viruses.
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T he ultimate goal of influenza vaccinology is the development of a universal vaccine that protects against a wide range of strains and subtypes, thereby eliminating the need for seasonal reformulation of vaccines and providing an effective defense against viruses with pandemic potential. The relatively recent discovery of broadly neutralizing human monoclonal antibodies (bnAbs) against influenza viruses (1) (2) (3) (4) (5) (6) (7) (8) has raised hopes that a broadly protective vaccine may indeed be feasible (9) (10) (11) (12) (13) . Because the majority of these bnAbs are directed toward highly conserved conformational epitopes in the hemagglutinin (HA) stem (1, 2, 4, 5, 7), this region may have the potential to induce broad protective immunity, provided it is well exposed and properly presented.
Various strategies to enhance exposure of the HA stem to the immune system are being explored, including presentation on self-assembling nanoparticles (14) , chimeric HAs (15, 16) , epitope transplantation on a virus-like particle (17) , and immune refocusing (18) . Yet another approach involves removal of the HA head while stabilizing the HA stem. A prerequisite for generating a broadly protective soluble HA stem immunogen is that it is stable and structurally resembles the stem of full-length (FL) HA. This simple and elegant concept is complicated by serious structural constraints (19) . HA is a metastable trimeric surface glycoprotein (20, 21) that undergoes extensive conformational rearrangements at low pH (22) . Removal of the transmembrane domain and HA head without extensive structural modifications to stabilize the remaining molecule inevitably leads to loss of native conformation of the HA stem (19) and concomitant loss of conformational bnAb epitopes. Previously reported soluble HA stem-derived immunogens have exhibited lower affinity with bnAbs relative to FL HA, indicating suboptimal conformation (23) (24) (25) (26) .
Design and initial characterization
Starting with the HA sequence of H1N1 A/Brisbane/ 59/2007, changes were introduced using a combination of rational design and library approaches (27) . In the first design phase (stages I to III; Fig. 1A ), we aimed to generate a soluble and stable HA stem monomer containing bnAb epitopes in the correct conformation, whereas in the final stages (stages IV and V), we aimed to create a mini-HA in its natural trimeric form. Details on the design, sequences, and screening are outlined in (27) and figs. S1 and S2. As a readout for a native-like stem conformation of the mini-HA constructs, we used the binding of bnAbs CR9114 and CR6261 (both of which recognize epitopes in the HA stem) (28) . From each design stage, the best-performing candidates were selected for further optimization. Key mutations in these lead candidates are schematically depicted in fig. S2 and on a model structure of mini-HA in Fig. 1B .
Selected mini-HAs #4157 (stage II), #4454 (stage III), #4650 (stage IV), and #4900 (stage V) were expressed in human embryonic kidney (HEK) 293F cells and purified. On the basis of size, mini-HAs #4157 and #4454 appeared predominantly monomeric in solution; #4650 was larger, suggesting at least partial formation of dimers, whereas #4900 appeared trimeric ( fig.  S3A ). Formation of an intermonomer cysteine bridge in trimeric mini-HA #4900 was confirmed using SDS-polyacrylamide gel electrophoresis under nonreducing and reducing conditions ( fig. S3B ). All selected mini-HA constructs have four putative N-linked glycosylation sites (Fig.  1B) . Under reducing conditions, the mini-HA bands were diffuse and ran at higher molecular weight (35 to 45 kD) than expected (29 kD), indicating that the mini-HAs were glycosylated ( fig. S3B ). Accordingly, deglycosylation with peptide-N-glycosidase F resulted in sharper bands (~30 kD, as for mini-HA #4900 in fig.  S3B ). The glycans appear relevant for proper folding, as attempts to efficiently produce mini-HA with retention of bnAb epitopes in bacteria were not successful (29).
Size exclusion chromatography with inline multi-angle light scattering (SEC-MALS) analysis revealed a single peak ( fig. S4A) , with average molecular weights of 40 kD for #4157 and #4454, 60 kD for #4650, and 108 kD for #4900 (Table 1) , which also indicated that #4157 and #4454 are monomeric in solution, #4650 forms dimers (at least in part), and #4900 forms trimers. In the presence of CR9114 or CR6261 Fabs, a peak shift to shorter retention time was observed for all mini-HAs, indicating formation of complexes ( fig. S4A ), which was confirmed by MALS (Table 1) , with masses in agreement with binding of one Fab (monomeric mini-HAs #4157 and #4454), one to two Fabs (dimeric mini-HA #4650), or three Fabs (trimeric mini-HA #4900) (30) .
Binding of CR9114 and CR6261 to all four candidate immunogens was in the nanomolar range, with affinity improving as the design process progressed (Table 1 and fig. S4B ). The strongest binding was exhibited by mini-HA #4900, with dissociation constant (K D ) values comparable to those of trimeric FL HA, indicating that this mini-HA recapitulates the bnAb epitopes and thus accurately mimics the native conformation of the HA stem.
Structural characterization
Modifications introduced throughout the design gradually increased the conformational stability as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) (31, 32) . In particular, modifications introduced in stage III (from #4157 to #4454) and stage V (from #4650 to #4900) stabilized the overall structure and the shorter A helix (Fig. 2) . Furthermore, we observed only a low level of deuterium exchange on the long CD helix of mini-HA #4900, likely due to the shielding effect caused by trimerization. Most important, the HDX pattern of mini-HA #4900 is very similar to that of trimeric FL HA, further demonstrating that the final design mimics the structure and dynamics of native HA. In line with these findings, the overall stability of the mini-HAs also evolved, as is apparent from measurements of the thermal stability ( fig. S5) .
Complexes of mini-HAs with CR9114 Fab were first studied by negative-stain electron microscopy (EM) (Fig. 3A) . The EM class averages illustrate the progression from monomeric (#4454) to a more heterogeneous mixture of monomers and dimers (#4650) and finally to a trimeric form (#4900). To provide further structural insights, we determined the crystal structures of #4454-CR9114 and #4900-CR9114 Fab complexes to 4.3 Å and 3.6 Å resolution, respectively (Fig. 3 , B and C, and table S1) (27) . In the #4454-CR9114 complex ( Fig. 3B ), CR9114 binds monomeric mini-HA and recognizes essentially the same epitope as in FL HA through contacts only with its heavy chain (table S2) (11) . The solvent-accessible surfaces of the CR9114 epitope residues in #4900 are similar to those in A/California/04/2009 FL H1 HA (table S3) sciencemag.org SCIENCE Table 1 . Binding of bnAbs to selected mini-HA candidates. bnAbs CR9114 and CR6261 form highaffinity complexes with mini-HAs. K D values were determined using biolayer interferometry and steadystate analysis. MALS analysis and size determination were used to confirm Fab binding and complex formation. The numbers are means and SDs of at least two independently produced protein batches. The values in parentheses represent the expected molecular weights for monomeric (#4157, #4454), dimeric (#4650), and trimeric (#4900) mini-HA-Fab complexes, using the determined molecular weight of the mini-HA and 48 kD for the Fabs. ( Fig. 3C) . The #4900 protomer is superimposable with an HA protomer from the H1 A/California/ 04/2009 trimer (PDB ID 4M4Y) with a C a RMSD of 1.2 Å, and only 1.0 Å for the CR9114 epitope residues. As a consequence of the removal of the HA1 head in #4900 and a more open trimer base (table S2) , some residues in the HA2 A helix, B loop, C and D helix, and E strand become solvent-accessible. These results convincingly demonstrate that the iterative design process led to antigens with an increasingly improved HA stem conformation and ultimately yielded HA-like stem antigens with a preserved CR9114 epitope.
Construct

In vivo effects
When tested in mice, all mini-HAs were highly immunogenic, eliciting high titers of antibodies binding to the FL HA of the A/Brisbane/59/2007 (H1N1) strain used as the basis for mini-HA generation ( fig. S7A ), as well as to FL HAs from a number of other group 1 (H1, H5, H9) and group 2 (H3, H7) influenza A strains ( fig. S7B ). These results demonstrate that antibodies induced with mini-HAs efficiently recognize epitopes that are present in native sequences of FL HA and are SCIENCE sciencemag.org Fig. 2 . Dynamic structural properties of miniHAs and trimeric FL HA analyzed by hydrogendeuterium exchange mass spectrometry. Relative deuterium uptake over time (0 to 60 min), illustrating the local dynamics of different structural units, is depicted on model mini-HA and FL HA structures using a color code from blue (1% deuterium uptake; highly protected) to red (100% deuterium uptake; highly exposed or flexible). conserved among different group 1 and even some group 2 influenza A strains (33) . Next, we evaluated the ability of mini-HA immunogens to provide protection against stringent lethal challenges and characterized the elicited immune response (Fig. 4 and fig. S7 ). Protection against influenza challenge with H1N1 A/PR/8/34 (heterologous to the parental strain used for design of the mini-HAs) was assessed after one, two, or three immunizations with miniHAs #2759 (monomer, long variant of #4157; fig.  S2 ), #4650 (mix of monomers and dimers), and #4900 (trimer). Mice immunized three times with monomeric mini-HA #2759 were only partially protected against mortality and showed severe weight loss and clinical symptoms, whereas #4650 and #4900 provided complete protection, with #4900-immunized mice showing neither weight loss nor clinical symptoms (Fig. 4A and fig. S7C ). Only mini-HA #4900 showed the same full protective ability when administered twice. Even after one immunization, #4900 exhibited 90% protection against mortality, although animals exhibited some (recoverable) weight loss and clinical symptoms, whereas #4650 and #2759
were not able to protect animals. Antibodies elicited with mini-HA #4900 after two and three immunizations competed with bnAb CR9114 for binding to the FL HA stem (Fig. 4A) , which shows that this mini-HA could readily elicit antibodies specific for bnAb stem epitopes.
Mice immunized three times with an expanded set of mini-HAs were challenged with heterosubtypic H5N1 A/Hong Kong/156/97 virus to evaluate the breadth of protection. Mini-HAs #2759 and #4157 (monomers) failed to elicit protection, #4454 (improved library monomer) and #4650 exhibited partial protection, whereas #4900 exhibited complete protection with neither weight loss nor clinical symptoms (Fig. 4B  and fig. S7D ). To further investigate antibodymediated effector mechanisms, we tested prechallenge sera in a neutralization assay using pseudoparticles derived from H5N1 A/Vietnam/ 1194/04 (34) . Sera from mice immunized with mini-HA #4900, and to some extent #4650, showed detectable neutralization, demonstrating the ability of these mini-HAs to elicit bnAbs (Fig. 4C ). Besides direct virus neutralization, Fc-mediated effector mechanisms, such as antibody-dependent cellular cytotoxicity (ADCC), contribute substantially to protection against influenza, with stemdirected bnAbs being particularly effective in these mechanisms (35) . We therefore used a mouse-adapted ADCC surrogate assay to test prechallenge sera (36) (37) (38) . The evolving miniHAs demonstrated an increasing ability to elicit antibodies with potential to induce ADCC (Fig.  4D) , with ADCC potency of serum antibodies corresponding to survival proportions observed in the H5N1 challenge model. In accordance with the binding data ( fig. S7, A and B) , mini-HA #4900 elicited ADCC responses to a wide range of group 1 influenza A HAs (fig. S7E ). To assess whether serum antibodies are indeed responsible for the observed in vivo protection, we passively transferred serum from mice immunized with #4650 and #4900 to naïve mice and subsequently challenged the recipient mice with A/HK/156/97 (H5N1) virus (Fig. 4E and fig. S7F ). In contrast to mice that received mock serum, mice that received serum from mini-HA-immunized mice were significantly protected, proving that antibodies play a key role in the protection elicited by mini-HAs. (E) Kaplan-Meier survival curves and mean body weight change for animals receiving serum from animals immunized three times with mini-HA or mock (n = 10 per group). Four weeks after the last immunization, serum was pooled and transferred to naïve recipient mice on three consecutive days before challenge, followed by challenge with 12.5 LD 50 H5N1 A/Hong Kong/ 156/97. Symbols indicate significantly improved survival proportion (Fisher's exact test; *), survival time (log-rank test; #) or body weight change (analysis of variance;^) relative to mock-immunized animals. Three symbols (i.e., ***, ###,^^) indicate P < 0.001, two symbols P < 0.01, and one symbol P < 0.05.
These combined results demonstrate that the progressive structural refinement and stabilization of mini-HAs directly translates to increasing ability to elicit stem-targeting, neutralizing, and ADCC-mediating antibodies that can protect mice against heterologous and heterosubtypic group 1 influenza strains, with trimeric #4900 exhibiting the most favorable features. In a recent study (26) , a bacterially produced trimeric HA stem construct also seemed more effective than monomeric versions in eliciting protection in an animal influenza challenge model.
We next tested the immunogenicity and protective efficacy of a three-dose regimen of mini-HA #4900 in six cynomolgus monkeys (Macaca fascicularis). As controls, groups of six monkeys received three injections of phosphate-buffered saline (PBS) or two human doses of a trivalent seasonal influenza vaccine (the standard of care for naïve children). As previously observed in mice, #4900 elicited high titers of antibodies in monkeys that were able to bind to a wide range of group 1 FL HAs (Fig. 5A and fig. S8A ); compete with stem-binding bnAb CR9114 for binding to homologous, heterologous, and heterosubtypic HAs (Fig. 5B) ; and elicit ADCC responses to these divergent HAs (Fig. 5C) . Furthermore, #4900 elicited H5N1 neutralizing antibodies that were detectable not only in a pseudoparticle-based neutralization assay ( fig. S8B) , as for the mouse sera (Fig. 4C) , but also in a standard microneutralization assay (Fig. 5D ). Relative to mockimmunized monkeys, animals vaccinated with mini-HA #4900 had significantly reduced fever after challenge with A/Mexico/InDRE4487/2009 (H1N1) virus (Fig. 5E and fig. S8E ) (39) , although no significant effect on the tracheal viral load was detected ( fig. S8C ). These results are comparable to those from monkeys vaccinated with the trivalent seasonal influenza vaccine (Fig. 5E and fig.  S8C ). However, the immune response elicited by mini-HA #4900 differed from the response elicited with the trivalent vaccine. As expected, vaccination with the seasonal vaccine, but not with "headless" #4900, elicited hemagglutinationinhibiting (HI) antibodies against A/California/ 07/09 (H1N1) virus, from which the H1 component of the trivalent vaccine is derived and which is closely related (two amino acid differences) to the A/Mexico/InDRE4487/2009 (H1N1) virus used to challenge the monkeys ( fig. S8D ). Furthermore, because the A/Texas/50/2012 HA antigen was present in the trivalent seasonal vaccine, the vaccine elicited higher antibody titers against this H3 strain than did mini-HA #4900 ( fig. S8A ). However, unlike the mini-HA-immunized monkeys, no antibodies able to compete with CR9114, induce ADCC, or neutralize H5N1 virus were detectable in the sera of monkeys immunized with the seasonal vaccine (Fig. 5, B to E, and fig. S8B ); these results show that the mini-HA elicited a qualitatively different and much broader immune response than the seasonal vaccine.
In these in vivo studies, we used a single antigen dose and a potent adjuvant. Although this adjuvant has not yet been registered for human use, it has been tested in a number of clinical trials with favorable safety and immunogenicity outcomes (40) . Future studies will need to address the minimal doses of mini-HA and adjuvant for a protective response. Because preexisting immunity may have a profound effect on the breadth of the response and no animal model recapitulates the complex preexisting immunity against influenza found in humans, such studies should be performed in humans (41) .
Concluding remarks
We have described the design and characterization of a series of soluble HA immunogens solely composed of the HA stem. Although all selected mini-HAs elicited comparable levels of antibodies to FL HA, the breadth and protective ability of the elicited antibodies progressively increased with the structural evolution of mini-HA configuration. The final candidate-stabilized trimeric mini-HA #4900-demonstrated its unique ability to elicit broad and protective immune response in mice and nonhuman primates. It has been reported (42, 43) William A. Goddard III, 3 Julia R. Greer 1, 7 Metallic glasses are metallic alloys that exhibit exotic material properties. They may have fractal structures at the atomic level, but a physical mechanism for their organization without ordering has not been identified. We demonstrated a crossover between fractal short-range (<2 atomic diameters) and homogeneous long-range structures using in situ x-ray diffraction, tomography, and molecular dynamics simulations. A specific class of fractal, the percolation cluster, explains the structural details for several metallic-glass compositions. We postulate that atoms percolate in the liquid phase and that the percolating cluster becomes rigid at the glass transition temperature.
F reeze a liquid fast enough, and it becomes a glass, a material that is structurally similar to the liquid but incapable of flow. This concept, albeit not well understood (1, 2) , is so ubiquitous that it holds even for metals (3). Vitrified metals, or metallic glasses, are a class of disordered materials with nondirectional bonding and possess a suite of lucrative mechanical properties, such as high elastic limit and strength (4) . Unlike most crystalline metals and alloys, metallic glasses earn their name from a lack of long-range atomic order and the absence of typical defects, such as dislocations, rendering their microstructure challenging to conceptualize
